Skip to main content
Sign In
HHS Logo
U.S. Department of Health & Human Services
Search Icon
Menu Icon

Evaluation and Performance Measures: 
5.0 Network Development Measures

Regional Ebola and Other Special Pathogen Treatment Center FY21 Administrative Supplemental Funding Performance Measures


Operational Intent: These performance measures examine the activities that have been implemented to achieve the following outcomes:

  • Support continued planning, development, and implementation of a national system forspecial pathogen patient care[4], including engaging state and jurisdiction special pathogen treatment centers; and other health care facilities (including but not limited to settings such as nursing homes, residential care facilities, EMS, and 911 call centers)

  • Support NETEC in their activities as a ‘force amplifier’ in their region
Required Program
Performance Measure
Data Point(s)
Data Entity
Calculation
PM 8: Promising practices
developed to support the
continued planning,
development, and system for special pathogen patient care
What promising practices
have you developed to
help achieve the continued
planning, development, national system for special pathogen patient care using RESPTC FY21 Administrative Supplement funds? What impact did you achieve? (Free response – 750-character response length)

 RESPTC
Qualitative description of
promising impact achieved
PM 9: Challenges encountered by RESPTCs in the continued planning, development, and implementation of a national system for special pathogen patient care

 What specific challenges have you encountered regarding your ability to plan, develop, and implement a national system for special pathogen care across sites? (Select all that apply)

  • Coordinating and communicating across facilities and partners (free response – 300-character response length)
  • Incentivizing participation from key stakeholders (free response – 300-character response length)
  • Aligning regional workplans with national NETEC initiatives (free response – 300-character response length)
  • Other (free response – 600-character response length)
Please briefly describe the impact of these challenges (free response – 600-character response length) 		RESPTC
Number of RESPTCs reporting each challenge

Qualitative description of challenges and impact of challenges
PM 10: Promising practices implemented by RESPTCs to access and use information and resources from NETEC
Which of the following promising practices did your RESPTC employ to access and use NETEC information and resources using RESPTC FY21AdministrativeSupplement funds? (Select all that apply)

  • Utilized NETEC resources to improve operations and clinical outcomes within my RESPTC
  • Shared NETEC resources with other health care facilities, organizations, and staff
  • Participated in the provision of technical assistance by NETEC Subject Matter Experts (SMEs) for facilities in my region
  • Utilized the NETEC infrastructure to support capacity and capability to participate in emergency clinical research[5]
  • Other (free response – 750-character response length)
RESPTC
Number of RESPTCs
implementing each listed
promising practice
  
PM 11: Promising practices used that promote coordination and collaboration between RESPTCs and other regional disaster response organizations[6]

 What promising practices did your organization use to collaborate with other regional organizations for disaster response (e.g.,  Regional Disaster Health Response System demonstration sites, Health Care Coalitions, etc.) using RESPTC FY21 Administrative Supplement R funds? What impact did you achieve? (Free response – 750-character response length)

 RESPTC Qualitative description of promising practices,  partners, and impact achieved
PM 12: Promising practices associated with RESPTC initiatives to support the region’s special pathogen system of care

 What promising practices did your organization use to support the region’s special pathogen system of care using RESPTC FY21 AdministrativeSupplement funds? What impact did you achieve? (Free response – 750-character response length)

 RESPTC Number of RESPTCs implementing initiatives Qualitative description of initiatives and impact achieved
PM 13: Challenges encountered during implementation of RESPTC initiatives that support the region’s special pathogen system of care

 What specific challenges have you encountered regarding implementation of regional treatment center initiatives to support your region’s special pathogen system of care using RESPTCFY21 AdministrativeSupplement funds? What were the impacts of these challenges? (Free response – 750-character response length)

 RESPTC
 Number of RESPTCs reporting challenges

Qualitative description of challenges and impact of challenges




4. Funding for RESPTCs in FY21 built on previous Ebola programming, which specified this activity at the regional level. Due to the COVID-19 pandemic, ASPR sought to evolve the regional system already established through Ebola funding into a National Special Pathogen System (NSPS). In order to capture the true intent of RESPTCs’ role in this system, this document refers to a “national system for special pathogen patient care.” RESPTCs continue to operate regionally within this national system.

5. The Hospital Preparedness Program (HPP) Ebola Preparedness and Response Activities cooperative agreement (CFDA #93.817) Part B permits Regional Ebola and Other Special Pathogen Treatment Centers to participate in clinical research, clinical trials, and experimental protocols, if appropriate, but recipients may not use cooperative agreement funds for research.

6. Note: A similar question appears in performance measures for the RESPTC COVID-19 Preparedness and Response Activities Administrative Supplement. Please limit this particular response to activities and outcomes funded by the RESPTC FY21 Administrative Supplement.



N​ext >>                                      ​​            ​                                                                                                                  << B​ac​​k
​

RESPTC FY21 Administrative Supplemental Funding
PMI Guide